Abbott Laboratories
ABT
₹10,948
Share price
-0.15%
Change (1 day)
24.77%
Change (1 year)
Categories
Abbott Laboratories (ABT), (founding name: Abbott Alkaloid Company) is a global pharmaceutical company with around 73,000 employees in 150 countries. Abbott was founded in 1888 by Wallace C. Abbott (1857-1921) and is headquartered in Abbott Park, a northern suburb of Chicago, Illinois.
Abbott Laboratories (ABT) - Total debt
Total debt on the balance sheet as of March 2025 : ₹1.147 Trillion
According to Abbott Laboratories's latest financial reports the company's total debt is ₹1.147 Trillion. A company’s total debt is the sum of all current and non-current debts.
Abbott Laboratories - Total debt on balance sheet (from 1996 to 2025)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | ₹1.288 T | -0.95% |
| 2023-12-31 | ₹1.301 T | -11.25% |
| 2022-12-31 | ₹1.465 T | 3.63% |
| 2021-12-31 | ₹1.414 T | -1.56% |
| 2020-12-31 | ₹1.437 T | 6.65% |
| 2019-12-31 | ₹1.347 T | -1.52% |
| 2018-12-31 | ₹1.368 T | -23.27% |
| 2017-12-31 | ₹1.782 T | 19.23% |
| 2016-12-31 | ₹1.495 T | 150% |
| 2015-12-31 | ₹598.16 B | 20.54% |
| 2014-12-31 | ₹496.24 B | 22.43% |
| 2013-12-31 | ₹405.33 B | -63.85% |
| 2012-12-31 | ₹1.121 T | 37.49% |
| 2011-12-31 | ₹815.43 B | -3.81% |
| 2010-12-31 | ₹847.72 B | 11.02% |
| 2009-12-31 | ₹763.55 B | 38.8% |
| 2008-12-31 | ₹550.11 B | 14.77% |
| 2007-12-31 | ₹479.32 B | -12.8% |
| 2006-12-31 | ₹549.67 B | 84.14% |
| 2005-12-31 | ₹298.50 B | 1.65% |
| 2004-12-31 | ₹293.65 B | 7.68% |
| 2003-12-31 | ₹272.71 B | -11.46% |
| 2002-12-31 | ₹307.99 B | -12.43% |
| 2001-12-31 | ₹351.69 B | 384.34% |
| 2000-12-31 | ₹72.61 B | -25.2% |
| 1999-12-31 | ₹97.07 B | -26.32% |
| 1998-12-31 | ₹131.76 B | 23.29% |
| 1997-12-31 | ₹106.87 B | 28.33% |
| 1996-12-31 | ₹83.28 B |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | ₹4.527 T | 294.59% | 🇺🇸 USA |
 Pfizer PFE | ₹5.310 T | 362.85% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | ₹2.962 T | 158.19% | 🇺🇸 USA |
 Hologic HOLX | ₹219.30 B | -80.89% | 🇺🇸 USA |
 Medtronic MDT | ₹2.470 T | 115.35% | 🇮🇪 Ireland |
 Bristol-Myers Squibb BMY | ₹4.439 T | 286.94% | 🇺🇸 USA |
 Boston Scientific BSX | ₹1.014 T | -11.58% | 🇺🇸 USA |
 AstraZeneca AZN | ₹2.711 T | 136.32% | 🇬🇧 UK |
 Novartis NVS | ₹2.709 T | 136.14% | 🇨🇭 Switzerland |
 GlaxoSmithKline GSK | ₹2.063 T | 79.85% | 🇬🇧 UK |